ledisa glp 1 GLP-1 Patches Ledisa LLC

Tirzepatide: Dual Agonist with Long-Lasting Impact Tirzepatide takes things one step further by acting as a dual agonist of both GLP-1 and GIP receptors

For Healthcare Professionals (HCPs) Tailored approaches to GLP-1 RA treatment plans are needed to ensure sustainable weight loss strategies, improve patient adherence, and support healthier dietary intakes

Zhang Y, Gu Y, Ren H, et al

References Henquin, J

The 35-54 age cohort leads current adoption (currently using or have used recently) at 23%, and GLP-1 adoption has contributed to consistent reduction in reported obesity rates among U.S

This may be especially likely if you are transitioning off tirzepatide, the most powerful obesity treatment on the market, or have stepped down to a lower dose in order to reduce the risk of side effects